October 2005 Research News
Government Panel Issues New Guidelines for BRCA1 and BRCA2 Testing
Women with BRCA1 or BRCA2 abnormalities also are at increased risk of developing ovarian cancer. Read more…
Herceptin Plus Chemo Continues to Improve Survival
Early results show herceptin plus chemotherapy after surgery reduces risk of recurrence in women with early-stage, HER-2-positive breast cancer. Read more…
FDA Tells Doctors About Potential Heart Problems with Herceptin
A study has shown a significant increase in heart problems in women with early-stage, HER2-positive breast cancer receiving chemotherapy and Herceptin. Read more…
Arimidex After Two Years of Tamoxifen Reduces Recurrence in Post-Menopausal Women
After other forms of therapy (surgery, chemotherapy, and radiation), an aromatase inhibitor is recommended as the first hormonal therapy because it has more benefits and fewer serious side effects than tamoxifen. Read more…
An original video-on-demand educational initiative brought to you by Breastcancer.org and Comcast. Visit www.comcast.net/pinkribbon each week through the end of October for engaging, up-to-date videos and information about the fight to end breast cancer.